Current Oncology Reports

Article	Citations
COVID-19 and Cancer: a Comprehensive Review	191
Immune-Related Adverse Events (irAEs): Diagnosis, Management, and Clinical Pearls	182
Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences?	130
Clinical and Biological Features of Neuroendocrine Prostate Cancer	95
Update on Osteosarcoma	90
Targeting Apoptosis in Cancer	64
Update on Management of Squamous Cell Esophageal Cancer	59
Proteasome Inhibitor-Related Cardiotoxicity: Mechanisms, Diagnosis, and Management	53
Cardiotoxicity of Immune Checkpoint Inhibitors	51
The Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: on Subsets and Subsites	48
Immunotherapy for Non-melanoma Skin Cancer	46
Advanced imaging techniques for neuro-oncologic tumor diagnosis, with an emphasis on PET-MRI imaging of malignant brain tumors	45
New Insights into Mechanisms of Immune Checkpoint Inhibitor-Induced Cardiovascular Toxicity	43
Immunotherapy in Cervical Cancer	40
New Targets in Lung Cancer (Excluding EGFR, ALK, ROS1)	38
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors	37
Determination of Biological Age: Geriatric Assessment vs Biological Biomarkers	37
WEE1 Inhibitor: Clinical Development	36
The Landscape of Immunotherapy in Advanced NSCLC: Driving Beyond PD-1/PD-L1 Inhibitors (CTLA-4, LAG3, IDO, OX40, TIGIT, Vaccines)	34
Bystander effect of antibody–drug conjugates: fact or fiction?	34
Giant Cell Tumor of Bone: An Update	33
A Review of the Current State of Hospice Care in China	33
Gut Microbiome Modulation Via Fecal Microbiota Transplant to Augment Immunotherapy in Patients with Melanoma or Other Cancers	33
Post-Diagnostic Dietary and Lifestyle Factors and Prostate Cancer Recurrence, Progression, and Mortality	30
Acute Myeloid Leukemia in Children: Emerging Paradigms in Genetics and New Approaches to Therapy	30

Biological and Functional Biomarkers of Aging: Definition, Characteristics, and How They Can Impact Everyday Cancer Treatment	29
First-Line Management of Advanced High-Grade Serous Ovarian Cancer	29
Psychological Aspects to Consider in Breast Cancer Diagnosis and Treatment	29
Cognitive Behavioral and Mindfulness-Based Interventions for Smoking Cessation: a Review of the Recent Literature	29
Emerging Therapeutics for Patients with Triple-Negative Breast Cancer	28
The COVID-19 Pandemic and its Impact on the Cardio-Oncology Population	28
VEGF Receptor Inhibitor-Induced Hypertension: Emerging Mechanisms and Clinical Implications	27
Burkitt and Burkitt-Like Lymphomas: a Systematic Review	27
Anaplastic Thyroid Carcinoma: Current Issues in Genomics and Therapeutics	27
Application of PET Tracers in Molecular Imaging for Breast Cancer	27
The Microbiome and Gynecologic Cancer: Current Evidence and Future Opportunities	26
Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies	26
Management of Pigmented Villonodular Synovitis (PVNS): an Orthopedic Surgeon’s Perspective	25
Sequencing Endocrine Therapy for Metastatic Breast Cancer: What Do We Do After Disease Progression on a CDK4/6 Inhibitor?	25
Targeting KRAS in Colorectal Cancer	24
Present and Future of De-intensification Strategies in the Treatment of Oropharyngeal Carcinoma	24
Applying the New Guidelines of HER2 Testing in Breast Cancer	24
Ependymoma: Evaluation and Management Updates	24
Improving the Safety of Major Resection for Hepatobiliary Malignancy: Portal Vein Embolization and Recent Innovations in Liver Regeneration Strategies	24
ROS1 Targeted Therapies: Current Status	23
Fatty Acid Metabolism and Cancer Immunotherapy	23
Engineered T Cells: CAR T Cell Therapy and Beyond	23
Vitamin D and Cancer Survival: Does Vitamin D Supplementation Improve the Survival of Patients with Cancer?	23
FGFR Inhibitors: Clinical Activity and Development in the Treatment of Cholangiocarcinoma	23
Anti-angiogenesis Revisited: Combination with Immunotherapy in Solid Tumors	23
Current Advances in Immunotherapy for Glioblastoma	22
Checkpoint Inhibitor Pneumonitis: Mechanisms, Characteristics, Management Strategies, and Beyond	22
Multidisciplinary Outpatient Cancer Rehabilitation Can Improve Cancer Patients’ Physical and Psychosocial Status—a Systematic Review	22
Chronic Lymphocytic Leukaemia in 2020: the Future Has Arrived	22
The Physical Consequences of Chemotherapy-Induced Peripheral Neuropathy	22
Disparities in Lung Cancer Treatment	22
Bruton’s tyrosine kinase Inhibitors and Cardiotoxicity: More Than Just Atrial Fibrillation	22
New Checkpoint Inhibitors on the Road: Targeting TIM-3 in Solid Tumors	21
COVID and Lung Cancer	21
Identifying and Meeting the Needs of Adolescents and Young Adults with Cancer	21
The Treatment Landscape of Advanced Hepatocellular Carcinoma	21
Mixed Phenotype Acute Leukemia: Current Approaches to Diagnosis and Treatment	20
Prostate Cancer Immunotherapy—Finally in From the Cold?	20
Microwave Ablation, Radiofrequency Ablation, Irreversible Electroporation, and Stereotactic Ablative Body Radiotherapy for Intermediate Size (3–5 cm) Unresectable Colorectal Liver Metastases: a System	19
Cardiac Biomarkers in Patients with Cancer: Considerations, Clinical Implications, and Future Avenues	19
Cardiovascular Toxicity of Novel HER2-Targeted Therapies in the Treatment of Breast Cancer	18
Hyperprogressive Disease upon Immune Checkpoint Blockade: Focus on Non–small Cell Lung Cancer	18
Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications	18
Surgical Approach to Lymphedema Reduction	18
The Management of rNPC: Salvage Surgery vs. Re-irradiation	17
Hairy Cell Leukaemia	17
Cytokines in the Treatment of Melanoma	17
The Role of Malnutrition and Muscle Wasting in Advanced Lung Cancer	17
Statins as Potential Chemoprevention or Therapeutic Agents in Cancer: a Model for Evaluating Repurposed Drugs	17
Central Nervous System Involvement in Adults with Acute Leukemia: Diagnosis, Prevention, and Management	17

Neutrophil Extracellular Trapping Role in Cancer, Metastases, and Cancer-Related Thrombosis: a Narrative Review of the Current Evidence Base	17
Role of Platinums in Triple-Negative Breast Cancer	16
Management of the Small Renal Mass: a 2020 Update	16
DNA Repair Mechanisms and Therapeutic Targets in Glioma	16
Chemotherapy and Radiation-Associated Cardiac Autonomic Dysfunction	16
Updates in Cardiac Amyloidosis Diagnosis and Treatment	16
Desmoid Fibromatosis: Management in an Era of Increasing Options	16
Advances in Molecular Classification and Therapeutic Opportunities in Meningiomas	16
Richter Syndrome	16
Molecular Subgroups of Diffuse Large B Cell Lymphoma: Biology and Implications for Clinical Practice	15
Neurological Complications of CAR T Cell Therapy	15
Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?	15
Neurofibromatosis in the Era of Precision Medicine: Development of MEK Inhibitors and Recent Successes with Selumetinib	15
Clinical Development of Anti-TIGIT Antibodies for Immunotherapy of Cancer	15
Cancer Screening Among Older Adults: a Geriatrician’s Perspective on Breast, Cervical, Colon, Prostate, and Lung Cancer Screening	15
CAR-T Therapies in Solid Tumors: Opportunities and Challenges	15
Cancer Pain Management—New Therapies	15
Telemedicine in Cancer Care Beyond the COVID-19 Pandemic: Oncology 2.0?	15
Management of the Neck in Well-Differentiated Thyroid Cancer	15
Access to Therapy for Acute Myeloid Leukemia in the Developing World: Barriers and Solutions	15
Current Clinical Trial Landscape of OX40 Agonists	15
The Development of STING Agonists and Emerging Results as a Cancer Immunotherapy	14
IDH-Mutant Low-grade Glioma: Advances in Molecular Diagnosis, Management, and Future Directions	14
Progress Update in Pediatric Renal Tumors	14
Diagnostic and Therapeutic Considerations for Extramedullary Leukemia	14
Management of Acute Myeloid Leukemia (AML) in Older Patients	14
COVID-19 in Children with Cancer	14
Interventions that Facilitate Shared Decision-Making in Cancers with Active Surveillance as Treatment Option: a Systematic Review of Literature	14
Percutaneous Management of Cancer Pain	13
Treatment Options for Advanced Melanoma After Anti-PD-1 Therapy	13
Radiation Therapy and Mandibular Osteoradionecrosis: State of the Art	13
Early Therapeutic Interventions for Newly Diagnosed Glioblastoma: Rationale and Review of the Literature	13
The Evolving Role of Radiation Therapy in Patients with Metastatic Soft Tissue Sarcoma	13
Radiogenomics in Interventional Oncology	13
Review of New-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia	13
Palliative and End-of-Life Care for Sexual and Gender Minority Cancer Survivors: a Review of Current Research and Recommendations	13
Value and Quality of Care in Head and Neck Oncology	13
Radiation-Induced Cardiovascular Disease: Mechanisms, Prevention, and Treatment	13
Management of Upper Tract Urothelial Carcinoma	13
Global Perspectives on Palliative Care for Cancer Patients: Not All Countries Are the Same	13
State of Rehabilitation Research in the Head and Neck Cancer Population: Functional Impact vs. Impairment-Focused Outcomes	13
Role of Machine Learning and Artificial Intelligence in Interventional Oncology	12
Isocitrate Dehydrogenase, Patient-Reported Outcomes, and Cognitive Functioning of Glioma Patients: a Systematic Review	12
Locally Advanced Pancreatic Cancer: Percutaneous Management Using Ablation, Brachytherapy, Intra-arterial Chemotherapy, and Intra-tumoral Immunotherapy	12
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice?	12
Locally Advanced, Unresectable Non-Small Cell Lung Cancer	12
Rectal Neuroendocrine Neoplasms: Why Is There a Global Variation?	12
Is There a Role for Percutaneous Ablation for Early Stage Lung Cancer? What Is the Evidence?	12
Immune Checkpoint Inhibitor Rechallenge and Resumption: a Systematic Review	12
Current Approaches in Hepatoblastoma—New Biological Insights to Inform Therapy	12
The Combined Use of SBRT and Immunotherapy—a Literature Review	12
Rare Breast Cancer Subtypes	12
The Critical Role of Parents in Pediatric Cancer-Related Pain Management: a Review and Call to Action	12
Adult T-Cell Leukemia: a Comprehensive Overview on Current and Promising Treatment Modalities	12
Medulloblastoma: an Old Diagnosis with New Promises	12
Global Perceptions of Women on Breast Cancer and Barriers to Screening	12
Approaches to Non-Muscle-Invasive Bladder Cancer	12
Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment	12
Mitochondrial Inhibition: a Treatment Strategy in Cancer?	11
Alternative Checkpoints as Targets for Immunotherapy	11
CAR T-Cell Therapy in the Older Person: Indications and Risks	11
Vitamin D in Head and Neck Cancer: a Systematic Review	11
Triplet Therapy in Melanoma — Combined BRAF/MEK Inhibitors and Anti-PD-(L)1 Antibodies	11
Reaching Across the Aisle: Cardio-Oncology Advocacy and Program Building	11
Combined BRAF-Targeted Therapy with Immunotherapy in BRAF-Mutated Advanced Melanoma Patients	11
Cancer-Related Fatigue—Is There a Role for Complementary and Integrative Medicine?	11
What’s New in Percutaneous Ablative Strategies for Hepatocellular Carcinoma and Colorectal Hepatic Metastases? 2020 Update	11
Induction Chemotherapy for Advanced Oral Cavity Cancer	11
Updates on Surgical Management and Advances for Brain Tumors	11
What Do We Currently Know About Chronic Myeloid Leukemia (CML) and COVID-19?	11
Cancer Risk in the Heart Failure Population: Epidemiology, Mechanisms, and Clinical Implications	11
Current Role of Functional Imaging in the Management of Lymphoma	11
The Role and Impact of Minimal Residual Disease in NSCLC	11
Prehabilitative Exercise for the Enhancement of Physical, Psychosocial, and Biological Outcomes Among Patients Diagnosed with Cancer	11
Racial Disparity in Response to Prostate Cancer Systemic Therapies	11
Lymphoblastic Lymphoma: a Concise Review	11
Dendritic Cell Leukemia: a Review	10
Striving toward Improved Outcomes for Surgically Resectable Non-Small Cell Lung Cancer: the Promise and Challenges of Neoadjuvant Immunotherapy	10
BTK Inhibitors and CAR T-Cell Therapy in Treating Mantle Cell Lymphoma—Finding a Dancing Partner	10
Radiotherapy and Immunotherapy Combinations for Lung Cancer	10

The Underestimated and Overlooked Burden of Diarrhea and Constipation in Cancer Patients	10
Cardiovascular Toxicities of CAR T-cell Therapy	10
Effects of Yoga-Based Interventions on Cancer-Associated Cognitive Decline: a Systematic Review	10
Perioperative NSAIDs and Long-Term Outcomes After cancer Surgery: a Systematic Review and Meta-analysis	10
A New Generation of Vaccines in the Age of Immunotherapy	10
Acute Leukemia in Infants	10
Palliative Care in Paediatric Oncology: an Update	10
Cardiovascular Disease in Adult Cancer Survivors: a Review of Current Evidence, Strategies for Prevention and Management, and Future Directions for Cardio-oncology	10
Shifting Epidemiology of Hepatocellular Carcinoma in Far Eastern and Southeast Asian Patients: Explanations and Implications	10
Immunology of Lynch Syndrome	10
Liver Transplantation for Cholangiocarcinoma: Insights into the Prognosis and the Evolving Indications	10
Thermal Ablation for the Management of Papillary Thyroid Microcarcinoma in the Era of Active Surveillance and Hemithyroidectomy	10
Older Patients with Acute Myeloid Leukemia Deserve Individualized Treatment	10
Spectrum and Clinical Activity of PD-1/PD-L1 Inhibitors: Regulatory Approval and Under Development	10
New Treatments for Recurrent Uterine Cancer	10
Therapy of Peripheral T Cell Lymphoma: Focus on Nodal Subtypes	9
Neuroendocrine Tumors: a Relevant Clinical Update	9
Microtubule Inhibitors and Cardiotoxicity	9
Combined Inhibition of EGFR and VEGF Pathways in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis	9
Upfront Management of ALK-Rearranged Metastatic Non-small Cell Lung Cancer: One Inhibitor Fits All?	9
The Changing Landscape of Lymphoma Associated with HIV Infection	9
Approaches to First-Line Therapy for Metastatic Clear Cell Renal Cell Carcinoma	9
Novel Approaches to the Systemic Management of Uveal Melanoma	9
The Concept of Respite in Palliative Care: Definitions and Discussions	9
Immune Response Evaluation and Treatment with Immune Checkpoint Inhibitors Beyond Clinical Progression: Response Assessments for Cancer Immunotherapy	9
Improving Breast Cancer Responses to Immunotherapy—a Search for the Achilles Heel of the Tumor Microenvironment	9
Viral and Clinical Oncology of Head and Neck Cancers	8
Synovial Sarcoma: A Complex Disease with Multifaceted Signaling and Epigenetic Landscapes	8
Minimally Invasive Approaches for Thyroid Surgery—Pitfalls and Promises	8
Mixed Phenotype/Lineage Leukemia: Has Anything Changed for 2021 on Diagnosis, Classification, and Treatment?	8
Discontinuation of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: a Review of the Biological Factors Associated with Treatment-Free Remission	8
New Developments in Gastric Neuroendocrine Neoplasms	8
Developing Real-world Evidence-Ready Datasets: Time for Clinician Engagement	8
Liver-Directed Therapies for Neuroendocrine Neoplasms	8
AXL Inhibitors: Status of Clinical Development	8
The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic	8
Transitioning to a New Normal in the Post-COVID Era	8
Advances in the Management of Pediatric Sarcomas	8
Medicinal Mushroom Supplements in Cancer: A Systematic Review of Clinical Studies	8
Childhood Acute Leukemias in Developing Nations: Successes and Challenges	8
Updates on Imaging of Liver Tumors	8
3+7 Combined Chemotherapy for Acute Myeloid Leukemia: Is It Time to Say Goodbye?	8
Immune Oncology Biomarkers in Lung Cancer: an Overview	8
Diagnosis and Management of Stroke in Adults with Primary Brain Tumor	8
Antibiotic Management of Patients with Hematologic Malignancies: From Prophylaxis to Unusual Infections	8
Prostate-Specific Membrane Antigen (PSMA)-Targeted Radionuclide Therapies for Prostate Cancer	8
Biological Rationale for Peripheral Blood Cell–Derived Inflammatory Indices and Related Prognostic Scores in Patients with Advanced Non-Small-Cell Lung Cancer	8
Facilitating Transitions to Adulthood in Pediatric Brain Tumor Patients: the Role of Neuropsychology	8
An Update on FLT3 in Acute Myeloid Leukemia: Pathophysiology and Therapeutic Landscape	8
Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic	8
The Role of Neoadjuvant Therapy in Melanoma	8
Chemokine Receptor Antagonists: Role in Oncology	8
Effect of Post-diagnosis Physical Activity on Breast Cancer Recurrence: a Systematic Review and Meta-analysis	8
New Tyrosine Kinase Inhibitors for the Treatment of Gastrointestinal Stromal Tumors	7
Extracellular vesicles and their associated miRNAs as potential prognostic biomarkers in chronic lymphocytic leukemia	7
Oncolytic Viruses and Cancer Immunotherapy	7
Emerging Opportunities for Combining Locoregional Therapy with Immune Checkpoint Inhibitors in Hepatocellular Carcinoma	7
Immunotherapy in Anal Cancer	7
Circulating Tumour DNA in Melanoma—Clinic Ready?	7
Rare Adverse Events with Programmed Death-1 and Programmed Death-Ligand 1 Inhibitors: Justification and Rationale for a Systematic Review	7
Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer	7
Correction to: The COVID-19 Pandemic and its Impact on the Cardio-Oncology Population	7
Strategies Towards Improving Clinical Outcomes of Peptide Receptor Radionuclide Therapy	7
The Emerging Role of Next-Generation Imaging in Prostate Cancer	7
Carcinoid Heart Disease: a Review	7
Global Longitudinal Strain Monitoring to Guide Cardioprotective Medications During Anthracycline Treatment	7
Enhanced Recovery After Surgery (ERAS) in Surgical Oncology	7
The Latest Option: Nivolumab and Relatlimab in Advanced Melanoma	7
Rehabilitation Needs for Patients Undergoing CAR T-Cell Therapy	7
The Role of Radiation Therapy in the Older Patient	7
Chemotherapy in Cutaneous Melanoma: Is There Still a Role?	7
Emerging Role of Biomarkers in Testicular Germ Cell Tumors	7
New Directions in Treatment of Metastatic or Advanced Pheochromocytomas and Sympathetic Paragangliomas: an American, Contemporary, Pragmatic Approach	7
Treatment Perspectives for Ovarian Cancer in Europe and the United States: Initial Therapy and Platinum-Sensitive Recurrence after PARP Inhibitors or Bevacizumab Therapy	7
Cancer Prehabilitation in Practice: the Current Evidence	7
Recent Advances and Applications of Radiation Therapy for Brain Metastases	7
Evolving Treatment Approaches to Mucosal Melanoma	7
Immune Checkpoint Inhibitors and Novel Immunotherapy Approaches for Breast Cancer	7
Novel Biomarkers in Sinonasal Cancers: from Bench to Bedside	7
Cancer Immunotherapies: What the Perioperative Physician Needs to Know	6
Guiding Treatment Choices for Elderly Patients with Glioblastoma by a Comprehensive Geriatric Assessment	6
Chronic Myelogenous Leukemia in Childhood	6
Richter’s Transformation	6
New Insights on Tramadol and Immunomodulation	6
How Should We Approach Locally Advanced Squamous Cell Carcinoma of Head and Neck Cancer Patients Ineligible for Standard Non-surgical Treatment?	6
Diffuse Large B-Cell Lymphoma in the Elderly: Current Approaches	6
Tumor Biomarkers and Interventional Oncology: Impact on Local Outcomes for Liver and Lung Malignancy	6
Robotic Head and Neck Surgery: Beyond TORS	6
Resistance to Poly (ADP-Ribose) Polymerase Inhibitors (PARPi): Mechanisms and Potential to Reverse	6
Surgical Management of Melanoma: Advances and Updates	6
Mitochondrial Dynamin-Related Protein Drp1: a New Player in Cardio-oncology	6
Extended Endocrine Therapy for Early-Stage Breast Cancer: How Do We Decide?	6
Breast Cancer Survivorship: the Role of Rehabilitation According to the International Classification of Functioning Disability and Health—a Scoping Review	6
Systematic Reviews and Meta-Analyses of Portal Vein Embolization, Associated Liver Partition and Portal Vein Ligation, and Radiation Lobectomy Outcomes in Hepatocellular Carcinoma Patients	6
Dealing with Family Conflicts in Decision-making in End-of-Life Care of Advanced Cancer Patients	6